These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 19883159)

  • 21. Memory B cell responses to Vibrio cholerae O1 lipopolysaccharide are associated with protection against infection from household contacts of patients with cholera in Bangladesh.
    Patel SM; Rahman MA; Mohasin M; Riyadh MA; Leung DT; Alam MM; Chowdhury F; Khan AI; Weil AA; Aktar A; Nazim M; LaRocque RC; Ryan ET; Calderwood SB; Qadri F; Harris JB
    Clin Vaccine Immunol; 2012 Jun; 19(6):842-8. PubMed ID: 22518009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diarrhoeal outbreak of Vibrio cholerae 01 Inaba in Delhi.
    Rajeshwari K; Gupta A; Dubey AP; Uppal B; Singh MM
    Trop Doct; 2008 Apr; 38(2):105-7. PubMed ID: 18453505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a new dipstick (Cholkit) for rapid detection of Vibrio cholerae O1 in acute watery diarrheal stools.
    Sayeed MA; Islam K; Hossain M; Akter NJ; Alam MN; Sultana N; Khanam F; Kelly M; Charles RC; Kováč P; Xu P; Andrews JR; Calderwood SB; Amin J; Ryan ET; Qadri F
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006286. PubMed ID: 29538377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Major Shift of Toxigenic V. cholerae O1 from Ogawa to Inaba Serotype Isolated from Clinical and Environmental Samples in Haiti.
    Alam MT; Ray SS; Chun CN; Chowdhury ZG; Rashid MH; Madsen Beau De Rochars VE; Ali A
    PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005045. PubMed ID: 27716803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and immunogenicity study of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine Shanchol, in Bangladeshi adults and children as young as 1 year of age.
    Saha A; Chowdhury MI; Khanam F; Bhuiyan MS; Chowdhury F; Khan AI; Khan IA; Clemens J; Ali M; Cravioto A; Qadri F
    Vaccine; 2011 Oct; 29(46):8285-92. PubMed ID: 21907255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of systemic, mucosal and memory antibody responses targeting Vibrio cholerae O1 O-specific polysaccharide (OSP) in adults following oral vaccination with an oral killed whole cell cholera vaccine in Bangladesh.
    Akter A; Dash P; Aktar A; Jahan SR; Afrin S; Basher SR; Hakim A; Lisa AK; Chowdhury F; Khan AI; Xu P; Charles RC; Kelly M; Kováč P; Harris JB; Bhuiyan TR; Calderwood SB; Ryan ET; Qadri F
    PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007634. PubMed ID: 31369553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of stable Vibrio cholerae O1 Hikojima type vaccine strains co-expressing the Inaba and Ogawa lipopolysaccharide antigens.
    Karlsson SL; Ax E; Nygren E; Källgård S; Blomquist M; Ekman A; Benktander J; Holmgren J; Lebens M
    PLoS One; 2014; 9(11):e108521. PubMed ID: 25397871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of a novel protective monoclonal antibody that recognizes an epitope common to Vibrio cholerae Ogawa and Inaba serotypes.
    Dharmasena MN; Krebs SJ; Taylor RK
    Microbiology (Reading); 2009 Jul; 155(Pt 7):2353-2364. PubMed ID: 19389772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unique Clones of Vibrio cholerae O1 El Tor with Haitian Type ctxB Allele Implicated in the Recent Cholera Epidemics from Nigeria, Africa.
    Adewale AK; Pazhani GP; Abiodun IB; Afolabi O; Kolawole OD; Mukhopadhyay AK; Ramamurthy T
    PLoS One; 2016; 11(8):e0159794. PubMed ID: 27479360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A duplex vibriocidal assay to simultaneously measure bactericidal antibody titers against Vibrio cholerae O1 Inaba and Ogawa serotypes.
    Yang JS; Choi S; Kim DD; Kang SS; Yun CH; Lee K; Han SH
    J Microbiol Methods; 2009 Dec; 79(3):289-94. PubMed ID: 19796659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Memory B cell and other immune responses in children receiving two doses of an oral killed cholera vaccine compared to responses following natural cholera infection in Bangladesh.
    Leung DT; Rahman MA; Mohasin M; Patel SM; Aktar A; Khanam F; Uddin T; Riyadh MA; Saha A; Alam MM; Chowdhury F; Khan AI; Charles R; LaRocque R; Harris JB; Calderwood SB; Qadri F; Ryan ET
    Clin Vaccine Immunol; 2012 May; 19(5):690-8. PubMed ID: 22441386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthetic fragments of Vibrio cholerae O1 Inaba O-specific polysaccharide bound to a protein carrier are immunogenic in mice but do not induce protective antibodies.
    Meeks MD; Saksena R; Ma X; Wade TK; Taylor RK; Kovác P; Wade WF
    Infect Immun; 2004 Jul; 72(7):4090-101. PubMed ID: 15213154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunogenicity of a killed bivalent (O1 and O139) whole cell oral cholera vaccine, Shanchol, in Haiti.
    Charles RC; Hilaire IJ; Mayo-Smith LM; Teng JE; Jerome JG; Franke MF; Saha A; Yu Y; Kováč P; Calderwood SB; Ryan ET; LaRocque RC; Almazor CP; Qadri F; Ivers LC; Harris JB
    PLoS Negl Trop Dis; 2014 May; 8(5):e2828. PubMed ID: 24786645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and immunogenicity of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine in adults and children in Vellore, South India.
    Raghava Mohan V; Raj S; Dhingra MS; Aloysia D'Cor N; Singh AP; Saluja T; Kim DR; Midde VJ; Kim Y; Vemula S; Narla SK; Sah B; Ali M
    PLoS One; 2019; 14(6):e0218033. PubMed ID: 31211792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunochemical characterization of an Ogawa-Inaba common antigenic determinant of Vibrio cholerae O1.
    Villeneuve S; Boutonnier A; Mulard LA; Fournier JM
    Microbiology (Reading); 1999 Sep; 145 ( Pt 9)():2477-2484. PubMed ID: 10517600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emergence of tetracycline resistance in Vibrio cholerae O1 biotype El Tor serotype Ogawa from north India.
    Taneja N; Samanta P; Mishra A; Sharma M
    Indian J Pathol Microbiol; 2010; 53(4):865-6. PubMed ID: 21045454
    [No Abstract]   [Full Text] [Related]  

  • 37. Phase 1 evaluation of Vibrio cholerae O1, serotype Inaba, polysaccharide-cholera toxin conjugates in adult volunteers.
    Gupta RK; Taylor DN; Bryla DA; Robbins JB; Szu SC
    Infect Immun; 1998 Jul; 66(7):3095-9. PubMed ID: 9632571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Study of avidity of antigen-specific antibody as a means of understanding development of long-term immunological memory after Vibrio cholerae O1 infection.
    Alam MM; Arifuzzaman M; Ahmad SM; Hosen MI; Rahman MA; Rashu R; Sheikh A; Ryan ET; Calderwood SB; Qadri F
    Clin Vaccine Immunol; 2013 Jan; 20(1):17-23. PubMed ID: 23114701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changing Susceptibility Pattern of
    Parvin I; Shahunja KM; Khan SH; Alam T; Shahrin L; Ackhter MM; Sarmin M; Dash S; Rahman MW; Shahid ASMSB; Golam Faruque AS; Ahmed T; Chisti MJ
    Am J Trop Med Hyg; 2020 Aug; 103(2):652-658. PubMed ID: 32458788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vibrio cholerae O1 Ogawa Strains Carrying the ctxB7 Allele Caused a Large Cholera Outbreak during 2014 in the Tribal Areas of Odisha, India.
    Pal BB; Khuntia HK; Nayak SR; Mohanty A; Biswal B
    Jpn J Infect Dis; 2017 Sep; 70(5):549-553. PubMed ID: 28674316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.